• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ARCA biopharma Inc

+ Add to Watchlist

HQ13:GR

1.065 EUR 0.020 1.91%

As of 02:16:09 ET on 09/02/2014.

Snapshot for ARCA biopharma Inc (HQ13)

Open: 1.018 Day's Range: 1.018 - 1.065 Volume: 0
Previous Close: 1.045 52wk Range: 0.956 - 1.692 1-Yr Rtn: +8.67%

Stock Chart for HQ13

No chart data available.
  • HQ13:GR 1.065
  • 1D
  • 1M
  • 1Y
1.045
Interactive HQ13 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HQ13

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4900
Est. PEG Ratio -
Market Cap (M EUR) 22.38
Shares Outstanding (M) 21.01
30 Day Average Volume 171
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HQ13

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HQ13

Arca biopharma, Inc. develops genetically targeted therapies for heart failure and other cardiovascular diseases.

Michael R BristowPresident/CEOPatrick M WheelerChief Financial Officer
Christopher D OzeroffSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for HQ13

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil